AstraZeneca COVID-19 vaccine trial in United States remains on hold

Clay Curtis
September 15, 2020

Adar Poonawalla said in an interview with the Financial Times that Vaccines for coronavirus treatment will take nearly four to five years until everybody to be vaccinated on this planet. But, I haven't heard of anyone approaching even close to this level now, he told the FT. In India, over 30 vaccine candidates are in different stages of development, said Union Health Minister Harsh Vardhan on Monday. The company had promised up to 100 million doses of the vaccine for India by 2021.

The fact that some pharmaceutical companies delegate the risks associated with their vaccines to countries which buy them raises additional questions, the RDIF chief said. The deal was signed as part of Operation Warp Speed, the Trump administration's effort to accelerate development and production of vaccines and treatments to fight the coronavirus. He said: This must be done after the agreement, according to an official statement.

Russian Federation has said that over one billion people would receive its vaccine in 2020-21.

There will not be enough doses of a COVID-19 vaccine to reach everyone worldwide until at least 2024, according to the CEO of the world's largest vaccine producer.

Last week, AstraZeneca PLC suspended the trial of the coronavirus vaccine (recombinant) due to an unexplainable illness. "At the same time, the suspension of trials clearly showed the fallacy of the approach, when entire countries exclusively rely on novel and untested platforms when choosing a vaccine for widespread use, including the use of a monkey adenovirus vector or mRNA technology", Dmitriev said in a press release.

South Dakota's AG Reported Hitting Deer; It Was a Person
According to South Dakota Governor Kristi Noem , the South Dakota Highway Patrol will be conducting an investigation. He was also cited for a seat belt violation in 2017 and paid a $25 fine, according to state records.

Coronavirus Vaccine latest: The Coronavirus vaccine could be available in the U.S. before the end of this year, claimed American pharmaceutical company Pfizer CEO Albert Bourla.

Clinical trials of COVID-19 vaccine being developed by AstraZeneca and Oxford University have resumed in the United Kingdom after a brief safety pause.

The Serum Institute of India is working with five other global pharmaceutical firms, including AstraZeneca and Novavax, to develop a coronavirus vaccine, and may partner with Russia's Gamaleya Research Institute to produce the "Sputnik" vaccine. It was more important for Bourla that his scientists were able to work without any strings attached, he said.

Larger studies of the Imperial and Oxford vaccine are already under way, but this study aims to see if the vaccines might be more effective if they are inhaled.

Other reports by

Discuss This Article